Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RNAZ
#4268
TransCode Therapeutics, Inc. Common Stock
9.830
0
USD
+0.31%
Sector:
Atención Sanitaria
Básica:
USD
Profit Currency:
USD
Rango diario
Rango anual
Cambio diario
+0.31%
Monthly Change
+3.39%
6 month change
+3.39%
Cambio anual
+3.39%
Cierres anteriores
9.800
0
Open
9.750
0
Bid
9.830
0
Ask
9.833
0
Low
9.750
0
High
9.830
0
Volumen
9
Markets
Acciones
Atención Sanitaria
RNAZ
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
18.69 K
833.62 K
833.62 K
833.68 K
916.97 K
—
Valuation ratios
Enterprise value
—
—
—
-897.27 K
7.02 M
—
Price to earnings ratio
—
—
—
-0.07
0.47
—
Price to sales ratio
—
—
—
1
0.61
—
Price to cash flow ratio
—
—
—
0
0.01
—
Price to book ratio
—
—
—
0.63
-0.12
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.59
-0.81
0.92
-0.52
-0.93
-1.34
Return on equity %
-1.41
2.93
1.18
-0.7
-3.41
0.01
Return on invested capital %
-1 819.69
-5 498.91
-6 115.37
-19.33 K
-7 293.21
-38.24 K
Gross margin %
100
100
100
100
100
400
Operating margin %
1 376.48
-2 231.58
11.66 K
8 889.03
14.23 K
32.55 K
EBITDA margin %
—
—
—
—
—
—
Net margin %
1 475.63
-2 592.49
-44.5 K
9 005.63
15.15 K
-22.94 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
1.58
2.56
5.2
5.27
1.6
14.62
Inventory turnover
—
—
—
—
—
—
Asset turnover
-0.04
0.04
-0
-0
-0
0.03
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
1 036.75
1 846.9
18
5.04
4.92
1 874.85
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
119.55
456.03
67.34
8.88
3.4
535.65
Net current asset value per share
227.31
557.72
75.72
9.89
5.7
649.03
Tangible book value per share
103.96
-158.73
59.75
7.37
1.71
-89.89
Working capital per share
83.6
339.78
61.16
8.01
2.14
411.09
Book value per share
103.96
-158.73
59.75
7.37
1.71
-89.89
Noticias
TransCode licencia plataforma de terapia contra cáncer de vejiga de Unleash/n
TransCode licenses bladder cancer therapy platform from Unleash
Las acciones de TransCode Therapeutics se disparan tras la presentación de una modificación de IND
Acciones de TransCode Therapeutics suben tras presentar enmienda de IND
Las acciones de TransCode Therapeutics se disparan tras prometedor estudio sobre glioblastoma
Acciones de TransCode Therapeutics suben tras prometedor estudio sobre glioblastoma
TransCode Therapeutics stock soars after promising glioblastoma study
TransCode Therapeutics nombra a Jack E. Stover para su consejo de administración
TransCode Therapeutics appoints Jack E. Stover to board of directors
TransCode y Quantum Leap probarán terapia contra el cáncer en ensayo fase 2a
TransCode and Quantum Leap to test cancer therapy in phase 2a trial
TransCode Therapeutics nombra a Michel Janicot como director de desarrollo